57m
Orexo AB (ORXOY) reports a positive EBITDA for the full year, driven by cost reductions and stable Zubsolv revenues, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback